During the past decade, Virginia Commonwealth University General Clinical Research Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Commonwealth University General Clinical Research Center" #1 sponsor was "Virginia Commonwealth University" with 4 trials, followed by "Allergan" with 1 trials sponsored, "Genfit" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "GlycoMimetics Incorporated" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Commonwealth University General Clinical Research Center" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Commonwealth University General Clinical Research Center" are "Polycystic Ovary Syndrome" (3 trials), "Obesity" (2 trials), "Cardiovascular Diseases" (1 trials), "Depressive Disorder, Major" (1 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "Virginia Commonwealth University General Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Virginia Commonwealth University General Clinical Research Center" are "Drug" (8 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cilofexor" (1 trials), "Elafibranor 80mg" (1 trials), "Flutamide" (1 trials) and "Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Commonwealth University General Clinical Research Center" are 5 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Virginia Commonwealth University General Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Virginia Commonwealth University General Clinical Research Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Commonwealth University General Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".